Dual HIV infection uncommon in patients on antiretroviral therapy in a region with high HIV prevalence

AIDS Research and Human Retroviruses

Volumn 25, Issue 12, 2009, Pages 1225-1230

  Naidoo, Anneta Frances ^a   Parboosing, Raveen ^b   Gordon, Michelle Lucille ^b  

^a INKOSI ALBERT LUTHULI CENTRAL HOSPITAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; ENVELOPE GENE; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOUTH AFRICA; TREATMENT OUTCOME; VIRUS GENOME; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; PREVALENCE; SOUTH AFRICA; VIRAL LOAD; YOUNG ADULT;

EID: 73149117615     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0095     Document Type: Article

References (37)

1. Perelson A, Neumann A, Markowitz M, Leonard J, and Ho D: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science, New Series 1996;271:1582-1586.
2. Roberts J, Katarzyna B, and Kunkel T: The accuracy of reverse transcriptase from HIV-1. Science, New Series 1988; 242:1171-1173.
3. Pulsinelli G and Temin H: High rate of mismatch extension during reverse transcription in a single round of retrovirus replication. Genetics 1994;91:9490-9494.
4. Battula N and Loeb L: On the fidelity of DNA replication: Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase. J Biol Chem 1976;251(4):982-986.
5. Cavallo G and Cavallo R: [Retroviruses: Current classification system]. G Batteriol Virol Immunol 1986;79:288-294.
6. http:==www.hiv.lanl.gov=.
7. Thomson M, Delgado E, Herrero I, et al.: Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol 2002;83:107-119.
8. Dowling W, Kim B, Mason C, et al.: Forty-one near fulllength HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS Patient Care STDS 2002;16:1809-1820.
9. Thomson M, Pérez-Álvarez L, and Nájera R: Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002;2: 461-471.
10. Carr J, Ávila M, Carrillo M, et al.: Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001;15:F41-F47.
11. Yang R, Xia X, Kusagawa S, Zhang C, Ben K, and Takebe Y: On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS 2002;16:1401-1407.
12. Gottlieb GS, Nickle DC, Jensen MA, et al.: Dual HIV-1 infection associated with rapid disease progression. Lancet 2004;363:619-622.
13. Blackard JT, Cohen DE, and Mayer KH: Human immunodeficiency virus superinfection and recombination: Current state of knowledge and potential clinical consequences. Clin Infect Dis 2002;34:1108-1114.
14. Herbinger KH, Gerhardt M, Piyasirisilp S, et al.: Frequency of HIV type 1 dual infection and HIV diversity: Analysis of low- and high-risk populations in Mbeya Region, Tanzania. AIDS Res Hum Retroviruses 2006;22:599-606.
15. Steain M, Wang B, Yang C, et al.: HIV type 1 sequence diversity and dual infections in Kenya. AIDS Res Hum Retroviruses 2005;21:882-885.
16. Ramos A, Tanuri A, Schechter M, et al.: Dual and recombinant infections: An integral part of the HIV-1 epidemic in Brazil. Emerg Infect Dis 1999;5:65-74.
17. Grobler J, Gray CM, Rademeyer C, et al.: Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis 2004;190:1355-1359.
18. Brenner B, Routy J-P, Quan Y, et al.: Persistence of multidrug- resistant HIV-1 in primary infection leading to superinfection. AIDS 2004;18:1653-1660.
19. Smith D, Wonga J, Hightower G, et al.: HIV drug resistance acquired through superinfection. AIDS Patient Care STDS 2005;19:1251-1256.
20. National HIV and syphilis antenatal seroprevalence survey in South Africa 2005 (Health Do, ed.), 2006.
21. Quinn TC: Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc Natl Acad Sci USA 1994;91:2407-2414.
22. WHO: WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. World Health Organization, Geneva, Switzerland, http:==www .who.int=hiv=pub=guidelines=WHO%20HIV%20Staging.pdf, 2006.
23. Boom R, Sol C, Salimans M, Jansen C, Wertheim-van Dillen P, and van der Noordaa J: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28 495-503.
24. Thompson J, Higgins D, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 1994;22: 4673-4680.
25. Smith S, Overbeek R, Woese C, Gilbert W, and Gilbert PM: The Genetic Data Environment: An expandable GUI for multiple sequence analysis. Comput Appl Sci 1994;10:671-675.
26. Swofford K: PAUP 4.0: Phylogenetic Analysis with Parsimony (and Other Methods). Sinauer Associates, Sunderland, MA, 1999.
27. Posada D and Crandall K: Modeltest: Testing the model of DNA substitution. Bioinformatics 1998;14;817-818.
28. Rambaut A: FigTree: Tree Figure Drawing Tool v1.1.1., 2007.
29. Cheonis N: Dual HIV infection. Beta 2006;18:36-40.
30. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006;20:W13-W23.
31. Williamson C, Engelbrecht S, Lambrick M, et al.: HIV-1 subtypes in different risk groups in South Africa. Lancet 1995;346:782.
32. Hunt G and Tiemessen CT: Occurrence of additional NFkappaB- binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates. AIDS Res Hum Retroviruses 2000;16:305-306.
33. Naghavi MH, Schwartz S, Sonnerborg A, and Vahlne A: Long terminal repeat promoter enhancer activity of different subtypes of HIV type 1. AIDS Res Hum Retroviruses 1999;15:1293-1303.
34. Takeb EY, Kusagawa S, and Motomura K: Molecular epidemiology of HIV: Tracking AIDS pandemic. Pediatr Int 2004;46:236-244.
35. de Oliveira T, Engelbrecht S, van Rensburg EJ, et al.: Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: An indication of viral fitness? J Virol 2003;77:9422-9430.
36. Huang DD, Glesler TA, and Bremer JW: Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, and international HIV type 1 subtype reference and standards panel. AIDS Res Hum Retroviruses 2003;19:321-328.
37. Ball SC, Abraha A, Collins KR, et al.: Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 2003;77:1021-1038.